[1]
A. F. Mohamad, N. A. E. Warman, N. A. Zainordin, M. H. Awang, F. Z. M. Shah, and R. A. . Ghani, “RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL”, J ASEAN Fed Endocr Soc, vol. 39, no. S1, pp. 34–35, Jul. 2024.